Further Enhancing Non-pharmacologic Therapy for Incontinence

Status Completed

Clinical Trial Summary

To determine the mechanisms mediating the therapeutic efficacy of pelvic floor muscle exercises and biofeedback for urge urinary incontinence, as well as the characteristics of patients most likely to respond. By identifying the key components of this treatment, we hope to simplify it and make it more easily applicable, more effective, less expensive, and thus more useful for people with urge incontinence in the future.

Clinical Trial Description

Urinary incontinence (UI) is prevalent and morbid in the elderly, and its associated costs exceed $26 billion annually. Although effective therapy exists, it is underutilized. This is particularly true for non-pharmacologic therapies, which are at least as effective as drugs but safer, and recommended as the initial approach by every national panel. If therapies such as biofeedback (which targets pelvic muscles and detrusor suppression) are to become more widely used, they will require simplification, fewer and briefer sessions, less expensive equipment, and less sophisticated therapists. Unfortunately, such protocols cannot yet be devised because it is unknown which components are essential. We postulate that the mechanisms mediating effectiveness can be identified and that such knowledge will make it possible to enhance efficacy and to formulate more feasible and cost-effective protocols. Since reduction in UI correlates weakly with improved quality of life, however, it is important that biofeedback's impact on life quality be assessed concomitantly to ensure that formulation of such streamlined methods does not eliminate components essential for improved quality of life, even if they have no physiological correlates. We will address these issues by treating at least 150 elderly subjects with urge UI in an 8-week course of biofeedback. We will collect clinical and quality of life data and perform extensive physiologic testing on each subject at baseline and 8 weeks later. Improvement will be correlated with change in physiologic and quality of life parameters to identify the parameters that likely mediated it. Knowledge from this study should identify predictors and mechanisms mediating success of biofeedback; suggest ways that it could be further improved; facilitate development of less expensive, quicker, and more feasible protocols to deliver it (potentially permitting application to less motivated or cognitively impaired patients); and shed insight into mechanisms that may even improve efficacy of other interventions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00177541
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	February 2004
Completion date	September 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01786967` - Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)	Phase 3
Enrolling by invitation	`NCT01940367` - Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments	N/A
Recruiting	`NCT00437528` - Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity	Phase 1
Completed	`NCT04525105` - SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE
Terminated	`NCT02129816` - Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder	Phase 2/Phase 3
Terminated	`NCT01366066` - Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence	Phase 3
Completed	`NCT01559389` - Incontinence & Intimate Partners: Assessing the Contribution of Treatment	Phase 4
Completed	`NCT01166438` - Anticholinergic vs. Botox Comparison Study	Phase 3
Completed	`NCT00909181` - Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence	Phase 3
Terminated	`NCT03923348` - Pelvic Floor Muscle Training With Leva System for Urge Incontinence	N/A
Completed	`NCT01445834` - Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence	N/A
Completed	`NCT00498888` - The Long Term Outcomes of Rehabilitation and Drug Treatment for in Urgency Urinary Incontinence	N/A
Terminated	`NCT00373789` - Refractory Urge Incontinence and Botox Injections	Phase 3
Recruiting	`NCT01737411` - Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women	Phase 1/Phase 2
Recruiting	`NCT00770406` - Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence	Phase 1/Phase 2
Completed	`NCT00862745` - Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)	Phase 4
Completed	`NCT02311634` - A Comparison of Electrical Pudendal Nerve Stimulation and Transvaginal Electrical Stimulation for Urge Incontinence	N/A
Completed	`NCT01672190` - Lessening Incontinence by Learning Yoga	N/A
Completed	`NCT01619995` - Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.